Sellas Life Sciences
Price & Volume
Stats
See more52W Range | $0.77-$2.48 |
Market Cap | $212.3M |
Shares Short | 28M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | -82.5% |
Gross Profit (12 Mos) | $900,000 |
Diluted EPS | -$0.26 |
News
See moreYahoo Finance • 13 days ago
After-Hours Gainers: MGNX, SLS, KRMD, HYPR, WVE Post Sharp Moves Following Q3 Updates
Yahoo Finance • 28 days ago
Sellas Life Sciences Group Inc. (SLS) Advances Cancer Pipeline with $31M Funding and Upcoming R&D Showcase
Yahoo Finance • 30 days ago
SELLAS Life Sciences Group Announces Exercise of Existing Warrants Held by a Current Institutional Investor for $31 Million in Gross Proceeds
Yahoo Finance • 2 months ago
Sellas Life Sciences files to sell 19.69M shares of common stock for holders
About
CEO | Dr. Angelos M. Stergiou M.D., ScD h.c. |
CFO | Mr. John Thomas Burns CPA |
Address | 7 Times Square, New York, NY, United States, 10036 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 15 |
